Adicet Bio, Inc. (ACET) vs eXoZymes, Inc. (EXOZ)

A side-by-side comparison of Adicet Bio, Inc. and eXoZymes, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACET

Adicet Bio, Inc.

$61M

$6.50HealthcareDelayed quote: Oct 6, 2026, 10:54 AM EDT

EXOZ

eXoZymes, Inc.

$53M

$5.72HealthcareDelayed quote: Oct 6, 2026, 10:42 AM EDT

Total return — ACET vs EXOZ

growth of $100 · dividends reinvested · last 2y

ACET -66.3% (-42.0%/yr)EXOZ -36.2% (-20.1%/yr)EXOZ compounded faster over this window

ACET EXOZ

ACET vs EXOZ: by the numbers

•ACET is the larger company ($61M vs $53M market cap).

Metrics side by side

Valuation

Metric	ACET	EXOZ
P/B ratio	0.51	14.53

Profitability

Metric	ACET	EXOZ
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	-82.38%	-278.89%
ROIC	-79.68%	-157.40%

Growth (annualized)

Metric	ACET	EXOZ
Total return CAGR (5Y)	-44.24%	N/A

Go deeper

Full ACET analysis Full EXOZ analysis Interactive comparison tool

Dig into the metrics

Adicet Bio ROE eXoZymes ROE Adicet Bio operating margin eXoZymes operating margin Adicet Bio revenue growth eXoZymes revenue growth Adicet Bio free cash flow eXoZymes free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.